|
|
Volumn 8, Issue SUPPL. 1, 2009, Pages
|
|
Evidence-based medicine within a budget - Where should we spend our money?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
BUDGET;
COST EFFECTIVENESS ANALYSIS;
DECISION MAKING;
DRUG COST;
EVIDENCE BASED MEDICINE;
HEALTH CARE COST;
HEALTH CARE PERSONNEL;
HEALTH CARE QUALITY;
HEALTH CARE UTILIZATION;
HEALTH SERVICE;
HEART FAILURE;
HUMAN;
PRIORITY JOURNAL;
QUALITY ADJUSTED LIFE YEAR;
SALARY;
SECONDARY PREVENTION;
SHORT SURVEY;
|
|
EID: 77957157178
PISSN: 15674215
EISSN: None
Source Type: Journal
DOI: 10.1093/eurjhf/hfp013 Document Type: Short Survey |
|
Times cited : (2)
|
|
References (3)
|
